Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Return on Equity: 2011-2025

Historic Return on Equity for Rockwell Medical (RMTI) over the last 15 years, with Sep 2025 value amounting to -0.17%.

  • Rockwell Medical's Return on Equity fell 12.00% to -0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.17%, marking a year-over-year decrease of 12.00%. This contributed to the annual value of -0.02% for FY2024, which is 47.00% up from last year.
  • Rockwell Medical's Return on Equity amounted to -0.17% in Q3 2025, which was down 134.33% from -0.07% recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Return on Equity ranged from a high of 28.25% in Q1 2022 and a low of -4.79% during Q4 2021.
  • Its 3-year average for Return on Equity is -0.37%, with a median of -0.23% in 2024.
  • As far as peak fluctuations go, Rockwell Medical's Return on Equity skyrocketed by 2,923bps in 2022, and later slumped by 2,924bps in 2023.
  • Rockwell Medical's Return on Equity (Quarterly) stood at -4.79% in 2021, then spiked by 356bps to -1.24% in 2022, then spiked by 83bps to -0.41% in 2023, then skyrocketed by 39bps to -0.02% in 2024, then decreased by 12bps to -0.17% in 2025.
  • Its Return on Equity stands at -0.17% for Q3 2025, versus -0.07% for Q2 2025 and -0.01% for Q1 2025.